Measles Death Statistics in US 2026 | Death Rate, Cases & Facts

Measles Death Tracking in America 2026

Measles death tracking refers to how the Centers for Disease Control and Prevention (CDC) monitors, confirms, and reports fatalities linked to measles infection across the United States, using its national Measles Cases and Outbreaks surveillance system alongside state health department reporting. In 2026, this tracking has taken on new urgency. The US officially declared measles eliminated in 2000, meaning the disease no longer circulated continuously within the country — but that status is now under active review. As of July 23, 2026, the CDC had confirmed 2,318 measles cases for the year, already surpassing the full-year 2025 total and marking the highest annual case count since 1991. Deaths, while far rarer than cases, remain the most closely watched metric in this crisis, because they represent the starkest possible measure of what happens when a preventable disease finds unvaccinated populations.

Understanding measles death statistics in the US in 2026 requires grasping a critical fact: measles is not typically a fatal disease for most who contract it, but it is also never a harmless one. Historically, before the vaccine became available in 1963, measles killed 400 to 500 Americans every year, mostly children, out of the 3 to 4 million people infected annually. After elimination in 2000, US measles deaths became exceptionally rare — until 2025, when the country recorded its first measles deaths since 2015. This article breaks down verified CDC data on measles fatalities, case fatality rates, at-risk populations, and how the current US death toll compares to historical and global patterns.

Interesting Facts & Latest Measles Death Statistics in the US 2026

US MEASLES DEATH DATA — KEY FACTS (2026 VERIFIED, CDC)
══════════════════════════════════════════════════════════════
  2026 confirmed measles cases (as of July 23)   ████████████████████  2,318
  2026 confirmed measles deaths                  ░░░░░░░░░░░░░░░░░░░░  0 (so far)
  2025 confirmed measles deaths                  ███░░░░░░░░░░░░░░░░░  3
  2026 hospitalization rate                      ███░░░░░░░░░░░░░░░░░  7% (151/2,318)
  2025 hospitalization rate                      █████░░░░░░░░░░░░░░░  11% (243/2,289)
  Last US measles death before 2025              ░░░░░░░░░░░░░░░░░░░░  2015
  Pre-vaccine era annual US deaths (pre-1963)    ████████████████████  400-500/year
══════════════════════════════════════════════════════════════

Source: CDC Measles Cases and Outbreaks (cdc.gov/measles/data-research), updated July 24, 2026; CDC History of Measles; World Health Organization Measles Fact Sheet

The single most important fact in this table is the contrast between 2025 and 2026: despite 2026 case counts already exceeding all of 2025, the US has recorded zero confirmed measles deaths so far this year, compared to three deaths across all of 2025 — the first US measles fatalities since 2015. This is not a contradiction; it reflects a combination of factors including which specific communities and age groups have been affected by 2026’s outbreaks, improved clinical recognition and supportive care for severe cases, and the simple statistical reality that measles deaths, even during active outbreaks, remain uncommon events layered on top of a much larger case count.

The second critical fact is the hospitalization rate decline, from 11% of cases in 2025 to 7% in 2026. Hospitalization is one of the clearest early-warning indicators for death risk, since nearly every US measles fatality in the modern era has followed a period of hospitalization for severe complications like pneumonia or encephalitis. A falling hospitalization rate alongside rising case counts suggests that 2026’s outbreaks may be skewing toward age groups or clinical presentations associated with somewhat lower severity — though public health officials caution this could shift as the year progresses and outbreaks reach different populations.

US Measles Deaths by Year in 2026 (Historical Trend)

US MEASLES DEATHS — SELECTED YEARS SINCE ELIMINATION (2000-2026)
══════════════════════════════════════════════════════════════
  Pre-vaccine era (avg/year, before 1963)   ████████████████████  400-500
  2000 (elimination declared)               ░░░░░░░░░░░░░░░░░░░░  0
  2001-2014                                 ░░░░░░░░░░░░░░░░░░░░  0 (each year)
  2015                                      █░░░░░░░░░░░░░░░░░░░  1 (last death pre-2025)
  2016-2024                                 ░░░░░░░░░░░░░░░░░░░░  0 (each year)
  2025                                      ███░░░░░░░░░░░░░░░░░  3
  2026 (as of July 23)                      ░░░░░░░░░░░░░░░░░░░░  0
══════════════════════════════════════════════════════════════

Source: CDC History of Measles; CDC Measles Cases and Outbreaks, updated July 24, 2026

The 25-year gap between US measles deaths — from elimination in 2000 through most of the following two-and-a-half decades — stands as one of the clearest success stories in American public health, and it makes the 2025 fatalities all the more significant as a turning point. Even the historically large 2019 outbreak, which produced 1,274 cases and came close to threatening elimination status at the time, resulted in zero deaths, underscoring that case counts alone don’t automatically translate into fatalities. What changed in 2025 was not simply the volume of cases but their concentration among unvaccinated children and adults in communities with limited healthcare access, precisely the population most vulnerable to severe outcomes.

The fact that 2026’s case count has already eclipsed 2025’s full-year total without producing a single confirmed death (as of the most recent data) offers a measure of cautious relief, but public health officials are clear that this could change quickly. Measles deaths often occur weeks after initial infection, following complications like pneumonia or encephalitis that develop during a prolonged illness course, meaning the year’s final death toll may not be reflected in real-time case data with the same immediacy as case counts themselves.

US Measles Case Fatality Rate and Complications in 2026

MEASLES COMPLICATION RATES AMONG US CASES (CDC DATA)
══════════════════════════════════════════════════════════════
  Hospitalization (unvaccinated cases)     ████████████████████  ~20% (1 in 5)
  Pneumonia (children)                     ██████░░░░░░░░░░░░░░  ~5% (1 in 20)
  Encephalitis                             █░░░░░░░░░░░░░░░░░░░  ~0.1% (1 in 1,000)
  Death (historical case fatality ratio)   ▌░░░░░░░░░░░░░░░░░░░  ~0.1-0.2% (1-2 per 1,000)
  SSPE (rare, delayed, fatal)              ▏░░░░░░░░░░░░░░░░░░░  ~1 in 10,000 (higher in infants)
══════════════════════════════════════════════════════════════

Source: CDC Measles (Rubeola) Complications overview; CDC History of Measles; CNN Health measles tracking coverage citing CDC complication data

Measles’ case fatality ratio of roughly 1 to 2 deaths per 1,000 cases may sound low in isolation, but applied against a case count in the thousands, it explains why even a single outbreak year can produce multiple deaths where none occurred for a decade. The disease’s danger lies less in its overall lethality and more in its complication profile: about 1 in 5 unvaccinated people who contract measles will be hospitalized, and roughly 1 in 20 infected children develop pneumonia, the single most common cause of measles-related death in young children. Encephalitis, occurring in about 1 in 1,000 cases, carries a much higher individual fatality and permanent disability risk than the disease’s headline numbers suggest.

Perhaps the most sobering complication is subacute sclerosing panencephalitis (SSPE) — a fatal degenerative brain disease that can emerge 7 to 10 years after an apparently resolved measles infection, most often in people infected as young children. Unlike acute measles complications, SSPE has no treatment and is uniformly fatal once symptoms begin, making it a delayed and often-overlooked contributor to the true long-term measles death toll that doesn’t show up in same-year fatality statistics. Compounding all of this is measles’ well-documented “immune amnesia” effect, in which the virus damages previously acquired immune memory, leaving survivors more vulnerable to other infectious diseases for months or years after recovery — a mechanism increasingly cited by researchers as a hidden contributor to excess mortality following measles outbreaks.

Who Is Most at Risk of Measles Death in the US 2026

AGE DISTRIBUTION OF 2026 US MEASLES CASES (CDC DATA)
══════════════════════════════════════════════════════════════
  Ages 5-19                          ████████████████████  51% of cases
  Under age 5                        ████████░░░░░░░░░░░░  20% of cases
  Ages 20+                           ██████████░░░░░░░░░░  ~29% of cases
  Hospitalization rate, under age 5  ████░░░░░░░░░░░░░░░░  ~10%
══════════════════════════════════════════════════════════════

Source: CDC Measles Cases and Outbreaks, updated July 24, 2026; Red Book Online Outbreaks: Measles, American Academy of Pediatrics

The demographic pattern behind measles deaths in the US is remarkably consistent: nearly every fatality, in 2025 and historically, has occurred in someone who was unvaccinated. With 93% of all 2026 cases involving people who were unvaccinated or had unknown vaccination status, the disease is overwhelmingly finding susceptible hosts in exactly the population the MMR vaccine is designed to protect. Children under 5 face a disproportionate hospitalization risk — roughly 10% compared to lower rates in older age groups — because their immune systems and smaller airways make them more vulnerable to the pneumonia and respiratory complications that most often precede a measles death.

Infants too young to receive the first MMR dose (typically given at 12-15 months) represent a uniquely vulnerable population, since they depend entirely on herd immunity in their surrounding community for protection, alongside pregnant women, for whom measles infection carries elevated risks of complications, and immunocompromised individuals, who cannot mount an adequate immune response even if vaccinated. The 2025 fatalities — two unvaccinated children in Texas and one unvaccinated adult in New Mexico — fit this pattern precisely, reinforcing that the path to preventing further US measles deaths runs directly through closing vaccination gaps in exactly these highest-risk groups.

US Measles Deaths vs. Global Measles Deaths in 2026

US VS GLOBAL MEASLES MORTALITY BURDEN (WHO / CDC)
══════════════════════════════════════════════════════════════
  Global measles deaths (annual, WHO estimate)   ████████████████████  100,000+
  US measles deaths (2025)                       ▏░░░░░░░░░░░░░░░░░░░  3
  US measles deaths (2026, as of July)           ░░░░░░░░░░░░░░░░░░░░  0
  Global measles vaccine lives saved (2000-2024) ████████████████████  ~59 million
══════════════════════════════════════════════════════════════

Source: World Health Organization Measles Fact Sheet, updated 2025; CDC MMWR “Progress Toward Measles Elimination — Worldwide”

The gap between US measles deaths (single digits in recent years) and global measles deaths (over 100,000 annually) is almost entirely explained by vaccine access and healthcare infrastructure, not by any difference in the virus itself. The overwhelming majority of global measles deaths occur in children under 5 in low-income countries, where routine childhood immunization coverage remains well below the 95% threshold needed to prevent sustained transmission, and where children who do become severely ill often lack access to supportive hospital care, such as oxygen therapy and treatment for secondary bacterial infections, that dramatically reduces fatality risk in wealthier countries like the US.

This comparison carries an important warning for American public health, though: the same underlying vulnerability — unvaccinated populations with limited healthcare access — that drives the global death toll is precisely what has re-emerged in specific US communities in 2025 and 2026. The estimated 59 million lives saved globally by the measles vaccine since 2000 demonstrate the intervention’s effectiveness beyond question; the ongoing challenge, both globally and now again domestically, is ensuring that vaccine access actually translates into vaccine uptake in every community, not just on average across a country or state.

Preventing Measles Deaths: Vaccination and Herd Immunity in US 2026

KEY PREVENTION LEVERS AGAINST MEASLES DEATH — US 2026
══════════════════════════════════════════════════════════════
  MMR vaccine efficacy, 2 doses           ████████████████████  97%
  Herd immunity threshold required        ████████████████████  ~95%
  Current national kindergarten MMR rate  ██████████████████░░  92.5% (below threshold)
  States below 95% MMR threshold          ███████████████████░  39 states
══════════════════════════════════════════════════════════════

For a deeper look at how vaccination gaps are shaping the current outbreak landscape, our herd immunity statistics in the US breakdown covers exactly why the national 92.5% MMR rate falls short of the protection measles requires. Understanding the policy and behavioral roots of this gap is also covered in depth in our vaccine hesitancy statistics in the US report, while the broader question of whether the country retains its 25-year elimination status is tracked in our measles elimination status statistics coverage.

Source: CDC SchoolVaxView, Vaccination Coverage and Exemptions Among Kindergartners, 2024-2025 School Year; CDC Measles Cases and Outbreaks, updated July 24, 2026

Every measles death recorded in the US in 2025, and every hospitalization recorded so far in 2026, traces back to the same preventable gap: vaccination coverage that has fallen below the 95% threshold measles requires to prevent sustained community transmission. The 97% efficacy of the two-dose MMR vaccine means that, on an individual level, vaccination provides near-complete protection — the challenge is not vaccine effectiveness but reaching enough of the population to deny the virus the susceptible hosts it needs to spread and, ultimately, to kill.

The state-level variation tells the sharpest version of this story: Connecticut’s 98.2% coverage sits comfortably above the protective threshold, while Idaho’s 78.5% leaves a population gap wide enough for measles to spread essentially unchecked once introduced. With 39 states currently below the 95% threshold and roughly 286,000 kindergartners entering school each year without complete MMR documentation, the path to preventing further US measles deaths is not a matter of medical uncertainty — it is a matter of closing a well-understood and well-documented vaccination gap, community by community, before the next unvaccinated child or adult becomes the next case, the next hospitalization, or the next fatality.

Disclaimer: This research report is compiled from publicly available sources, including CDC surveillance data and World Health Organization reporting. While reasonable efforts have been made to ensure accuracy, no representation or warranty, express or implied, is given as to the completeness or reliability of the information. We accept no liability for any errors, omissions, losses, or damages of any kind arising from the use of this report.